Biotest is committed to combating the coronavirus

Activities of Biotest Group against the coronavirus

TV reports, press releases and the presentation of Biotest's research activities.

CoVIg-19 PLASMA ALLIANCE

Our product range

Our development pipeline

Phase 1

Phase 2

Phase 3

Approval

Launch

IgG Next Generation (BT595) - Primary Immune Deficiency (PID)
IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP)
Fibrinogen (BT524) - Congenital fibrinogen deficiency
Fibrinogen (BT524) - Acquired fibrinogen deficiency
Trimodulin (BT588) - Severe community acquired pneumonia
Haemophilia A Therapeutic (HAT) - Haemophilia A

Pipeline

Overview of all projects and their status from the therapy areas Haematology, Immunology and Intensive care medicine

Press releases

Biotest increases sales by more than 22 % in the first ...

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Annual General Meeting approves dividend distribution

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Correction of a release from 11/05/2021, 14:30 CET/CEST...

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens 10th plasma collection centre in Hunga...

06.05.2021,

06.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest confirms good tolerability and efficacy of Intr...

22.04.2021,

22.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest accelerates fibrinogen phase III study with add...

07.04.2021,

07.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest exceeds Sales and EBIT forecast in the 2020 fin...

31.03.2021,

31.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest supports clinical study with Pentaglobin(R) in ...

23.02.2021,

23.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest is the first plasma protein manufacturer in Ger...

18.02.2021,

18.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest significantly exceeds Revenue and EBIT guidance

11.02.2021,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Biotest significantly exceeds Revenue and EBIT guidanceDreieich, 11 February 2021. According to preliminary and not yet audit ... [More]

Release according to Article 40, Section 1 of the WpHG ...

01.02.2021,

01.02.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Release according to Article 40, Section 1 of the WpHG ...

11.01.2021,

11.01.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Biotests Pentaglobin(R) is a treatment option for COVID...

26.11.2020,

26.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest increases adjusted 9-month EBIT by over 21% to ...

12.11.2020,

12.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest treats first COVID-19 patient with trimodulin

06.10.2020,

06.10.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG:

04.10.2020,

04.10.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest is one of the first plasma protein manufacturer...

10.09.2020,

10.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest phase II study for the treatment of severe COVI...

03.09.2020,

03.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest achieves another important clinical milestone f...

01.09.2020,

01.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest increases sales in the first half of 2020 by ov...

13.08.2020,

13.08.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Careers

Careers

Passionate to help us save lives?

Investor Relations

Investor Relations

The primary objective of our Investor Relations activities is an open and up-to-date dialogue with the financial community.